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with Andersen-Tawil syndrome
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Andersen-Tawil syndrome is characterized by periodic paralysis, ventricular ectopy and dysmorphic features.
Approximately 60% of patients exhibit loss-of-function mutations in KCNJ2, which encodes the inwardly rectifying K+
channel pore forming subunit Kir2.1. Here, we report the identification of a novel KCNJ2 mutation (G211T), resulting
in the amino acid substitution D71Y, in a patient presenting with signs and symptoms of Andersen-Tawil syndrome.
The functional properties of the mutant subunit were characterized using voltage-clamp experiments on transiently
transfected HEK-293 cells and neonatal mouse ventricular myocytes. Whole-cell current recordings of transfected HEK293 cells demonstrated that the mutant protein Kir2.1-D71Y fails to form functional ion channels when expressed alone,
but co-assembles with wild-type Kir2.1 subunits and suppresses wild-type subunit function. Further analysis revealed
that current suppression requires at least two mutant subunits per channel. The D71Y mutation does not measurably
affect the membrane trafficking of either the mutant or the wild-type subunit or alter the kinetic properties of the
currents. Additional experiments revealed that expression of the mutant subunit suppresses native IK1 in neonatal mouse
ventricular myocytes. Simulations predict that the D71Y mutation in human ventricular myocytes will result in a mild
prolongation of the action potential and potentially increase cell excitability. These experiments indicate that the Kir2.1D71Y mutant protein functions as a dominant negative subunit resulting in reduced inwardly rectifying K+ current
amplitudes and altered cellular excitability in patients with Andersen-Tawil syndrome.
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Introduction

Andersen-Tawil syndrome is an autosomal dominant heritable
disorder associated with a triad of symptoms: periodic paralysis,
ECG changes and characteristic dysmorphic features.1 Although
the genetic cause remains enigmatic in some patients, approximately 60% have been found to have loss of function mutations
in KCNJ2, the gene which encodes the inwardly rectifying K+
(Kir) pore forming subunit, Kir2.1. This subunit contributes to
the inwardly rectifying K+ current (IK1) found in cardiac and a
wide variety of other cells.2
Although originally identified based on unusual rectification properties and large inward currents at hyperpolarized
membrane potentials, inwardly rectifying channels exhibit
a smaller, but physiologically crucial, conductance in the
more depolarized range of membrane voltages from -80 to
-40 mV. In this range, the current plays a role in modulating resting membrane potentials and in shaping the terminal
phase of action potential repolarization.3 Due to these roles,
alterations in IK1 amplitudes, densities, and/or properties may

stabilize re-entrant malignant arrhythmias such as ventricular
fibrillation.3
The channels underlying IK1 are tetramers of Kir2.x subunits.1
Kir2.1 (encoded by the KCNJ2 gene) appears to be an essential
subunit in ventricular myocytes and Kir2.2 also contributes to
IK1.4 The role(s) of Kir2.3 and 2.4 in cardiac tissue remains less
well defined although they have been shown to form heterotetramers with Kir2.1 and/or Kir2.2.5,6 Channel function is strongly
dependent on the membrane-associated second messenger phosphotidylinositolbisphosphate (PIP2), and outward currents are
blocked by positively charged intracellular species, most notably
polyamines, such as spermine, spermidine and putrescine, and by
magnesium ions, thereby generating the property of inward rectification.1 One intriguing region of the Kir α subunit is the “slide
helix” which is predicted to form an alpha helix lying parallel to
the cell membrane between the transmembrane and cytoplasmic
domains.7,8 Several Andersen-Tawil syndrome associated mutations have been identified in this region and suggested to disrupt
the association of the slide helix region with the regulatory cytoplasmic domain(s).9
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Figure 1. (A) Twelve-lead ECG from the patient demonstrates frequent ventricular ectopy (arrow) and prominent U waves (arrowhead). (B) Predicted
structure of Kir2.1 with two subunits of the tetramer removed for clarity. The ion selective pore, slide helix and N- and C-termini are indicated. (C) The
slide helix region is shown in greater detail. Colored residues of the slide helix indicate amino acids with hydrophobic side chains (yellow), hydrophilic
side chains (green), and the location of the D71Y mutation (red). Structure is based on the KirBac1.1 channel (PBD ID: 1P7B) and rendered using the
PyMOL Molecular Graphics System.25

Mutations in Kir2.1 have been associated with multiple
c ardiac electrical diseases, including catecholaminergic polymorphic ventricular tachycardia (CPVT), familial atrial fibrillation,
short QT syndrome and Andersen-Tawil syndrome (also called
long QT syndrome 7).1 To date, 33 loss of function mutations
in KCNJ2 have been associated with Andersen-Tawil syndrome.1
Loss of function mutations are located throughout the protein
and have been identified in the pore-forming domain, the PIP2
binding domain, the slide helix and regions involved in protein
trafficking.10
We report here the identification of a novel KCNJ2 mutation in
a patient with Andersen-Tawil syndrome. In this patient, a single
base pair mutation (G211T) results in a D71Y substitution in the
slide helix region of Kir2.1. Heterologous expression experiments
demonstrate that the mutant subunit fails to form functional
Kir channels when expressed alone, but suppress Kir2.1-encoded
currents when co-expressed with wild-type Kir2.1 subunits.
Co-expression of the mutant subunit, however, does not appear
to impair membrane localization of wild-type Kir2.1 subunits or
affect the time- or voltage-dependent properties of the currents.
Additional experiments demonstrate that expression of hKir2.1D71Y in mouse neonatal cardiomyocytes suppresses inwardly
rectifying currents (IK1), consistent with a functional impact of
this mutation on native cardiac IK1. Simulations using a human
www.landesbioscience.com

ventricular myocyte model predict that the reduction in IK1
resulting from the presence of the D71Y mutation will result in
prolongation of the terminal portion of the action potential and
altered cellular excitability.
Results
Patient presentation. In 2009, a 28-year-old Caucasian male
was admitted for further evaluation of periodic paralysis. His
symptoms started in January 2005 and resulted in four hospitalizations due to severe muscular weakness. Pertinent findings
on examination included bilateral syndactyly of toes 2–3 and
ECG tracings revealed frequent premature ventricular complexes
and bigeminy (Fig. 1A). Although the QTc interval was within
normal limits, there were prominent U-waves on the ECG. In
light of these combined findings, Andersen-Tawil syndrome was
suspected. The KCNJ2 gene (encoding Kir2.1) was sequenced,
revealing a heterozygous, single guanine to thymine base pair
change at position 211 (G211T) resulting in a single aspartic acid
to tyrosine substitution at position 71 (D71Y). Figure 1B shows
the overall structure of the Kir2.1 subunit and Figure 1C illustrates the slide helix region in more detail.
Kir2.1-D71Y mutation results in a non-functional
channel. To assess the functional consequences of the
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Figure 2. Kir2.1-D71Y fails to form functional channels and suppresses wild-type currents in HEK-293 cells. (A–D) Representative whole cell Kir currents
recorded in HEK-293 cells expressing td-tomato alone (A), or in the presence of Kir2.1-D71Y (B), wild-type Kir2.1 (C), or both wild-type Kir2.1 and Kir2.1D71Y in a 1:1 ratio (D) in response to voltage steps from -120 to -10 mV in 10 mV increments from a holding potential of -70 mV are illustrated. The currents were normalized to cell capacitance (in the same cell) and current densities are plotted; the dotted line indicates 0 pA/pF. (E and F) Current-voltage relationships for the currents measured in HEK-293 cells expressing td-tomato (diamond), Kir2.1-D71Y (triangle), wild-type Kir2.1 (closed squares),
or wild-type Kir2.1 and Kir2.1-D71Y in a 1:1 ratio (open squares) are plotted. The voltage range marked by the dashed rectangle in (E) is expanded in (F).
All values are means ± SEM. Current densities in cells co-expressing wild-type Kir2.1 and Kir2.1-D71Y were significantly (*p < 0.05) lower than in cells
expressing wild-type Kir2.1 alone.

identified Kir2.1-D71Y mutation, HEK-293 cells were
transiently transfected with td‑tomato together with either wildtype or mutant KCNJ2 cDNA. Expression of wild-type Kir2.1
resulted in strongly inwardly rectifying currents in HEK-293
cells (Fig. 2C) as well as a significant (p < 0.001) hyperpolarization of the resting membrane potential (mean ± SEM = -53 ± 2
mV; n = 21) compared to HEK-293 cells expressing td-tomato
alone (-29 ± 2 mV; n = 9). In contrast, expression of Kir2.1D71Y resulted in only small amplitude currents that were indistinguishable from currents present in HEK-293 cells expressing
td-tomato alone (Fig. 2A); mean ± SEM peak current densities
at -120 mV in cells expressing td-tomato alone (-8.4 ± 1.4 pA/
pF) or td-tomato plus Kir2.1-D71Y (-6.4 ± 0.5 pA/pF) were not
significantly different. Expression of either wild-type Kir2.1,
mutant Kir2.1, or co-expression of wild-type and mutant Kir2.1
did not result in significant changes in cell membrane capacitance or membrane resistance (data not shown).
Co-expression of Kir2.1-D71Y with wild-type Kir2.1
results in a reduction of the wild-type current. Because the
phenotypic manifestations of Andersen-Tawil syndrome are
evident in heterozygous carriers of KCNJ2 mutations, we next
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investigated the consequences of co-expression of Kir2.1-D71Y
with wild-type Kir2.1 (Fig. 2). Co-expression of the wild-type
and mutant subunits in a 1:1 ratio resulted in significantly
smaller currents (Fig. 2D) compared to expression of the same
amount of the wild-type subunit alone (Fig. 2C). For example, the mean ± SEM inward current density at -120 mV was
reduced significantly (p = 0.02) from -249.5 ± 50.3 pA/pF
(n = 21) in cells expressing wild-type Kir2.1 to -121.3 ± 23.5
pA/pF (n = 22) in cells co-expressing wild-type Kir2.1 and
Kir2.1-D71Y (Fig. 2E). Similarly, the mean ± SEM outward
current density at -50 mV was reduced (p = 0.01) from 4.6 ±
1.3 pA/pF in cells expressing wild-type Kir2.1 to 1.4 ± 0.5 pA/
pF in cells co-expressing wild-type Kir2.1 and Kir2.1-D71Y
(Fig. 2F). Co-expression of Kir2.1-D71Y with wild-type Kir2.1
also resulted in a small depolarizing shift in the resting membrane potential (-46.8 ± 3.0 mV) compared with cells expressing only wild-type Kir2.1 (-53.4 ± 1.3 mV), although this trend
was not statistically significant (p = 0.09). Taken together, these
observations suggest that Kir2.1-D71Y functions as a dominant negative subunit capable of suppressing the function of
wild‑type Kir2.1 subunits.
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Figure 3. Voltage-dependent activation and inactivation of currents produced by co-expression of wild-type Kir2.1 and Kir2.1-D71Y are
indistinguishable from currents produced by expression of wild-type Kir2.1 alone. (A) The time course of inward current activation was fitted with
a single exponential and the mean ± SEM time constants (tau) are plotted as a function of membrane voltage. (B) Mean ± SEM percent inactivation
determined at each voltage are plotted as a function of test potential.

Kir2.1-D71Y does not alter current kinetics. One possible
mechanism by which mutant subunit co-assembly with wild-type
subunits could result in decreased currents might be by increasing the binding affinity for one or more of the cytoplasmic agents
(polyamines and magnesium) responsible for blocking outward
currents through Kir2.1 channels.1 To explore this possibility, the
activation phases of the inward currents at hyperpolarized potentials, which reflect the unbinding of magnesium and polyamines
from the pore,11 were examined. Analyses of the time course of
inward current activation revealed an essentially instantaneous
phase followed by a slower phase that was well-described by a
single exponential; there were no improvement in the fits when
multiple exponential terms were included. The amplitude of the
instantaneous phase represented approximately 70% of the peak
current for both wild-type (72 ± 1%, n = 20) and wild-type:
D71Y heteromeric channels (74 ± 2%); these values are not significantly different. The time course of the slower phase of activation is voltage dependent as previously described in reference 11,
and the activation time constants were indistinguishable for
wild-type and wild-type:D71Y currents (Fig. 3A). The mean ±
SEM activation tau at -120 mV, for example, was 0.44 ± 0.03 ms
in cells expressing wild-type Kir2.1 and 0.40 ± 0.02 ms in cells
co-expressing wild-type and D71Y Kir2.1 (Fig. 3A).
Kir2.1 mediated currents also exhibit partial inactivation,
as evidenced by the attenuation of current from the initial peak
to a steady state plateau during a voltage step and, as previously
described in reference 12, the extent of the inactivation is voltage
dependent (Fig. 2C). Fractional current inactivation was quantified here by calculating the ratio of the peak current to the steady
state current. There were no significant differences between the
fractional inactivation of wild-type Kir2.1 and wild-type Kir2.1 +
Kir2.1-D71Y currents at any test potential (Fig. 3B). At -120 mV,
for example, the percent current inactivation during the 350 ms
voltage step was 22 ± 1% for wild-type Kir2.1 (n = 20) and 23
± 1% for wild-type Kir2.1 + Kir2.1-D71Y (n = 22). Together,
these observations demonstrate that IK1 in the presence of Kir2.1D71Y exhibits normal current kinetics; reflecting either that the
mutant subunits do not alter channel kinetics or that channels

containing one or more mutant subunits are non-functional and
the functional channels are entirely wild type (see Discussion).
Dominant-negative suppression of currents requires
co-assembly of mutant and wild-type subunits. It has previously been shown that Kir2.1 subunits assemble as tetramers.1 Subsequent experiments here, therefore, were aimed at
determining the minimal number of mutant subunits necessary
to suppress channel function by co-transfecting HEK-293 cells
with wild-type and mutant subunits in varying proportions.
Theoretical curves were constructed to predict the expected
current for each wild-type:mutant subunit ratio based on the
assumptions that: (1) the proportions of wild-type and mutant
subunit proteins in each cell reflects the relative proportion of
the transfected wild-type and mutant cDNA constructs and (2)
the probability of incorporation of a mutant subunit into a channel is equivalent to the proportion of mutant subunits expressed
in the cell. A separate theoretical curve was generated for the
scenarios in which 1, 2, 3 or 4 mutant subunits are required to
reduce channel function. As shown in Figure 4, the experimental
data deviate significantly from the curve predicted for only one
mutant subunit being required to eliminate channel function,
suggesting that more than one mutant subunit per channel complex is required to reduce channel function.
Membrane trafficking of Kir2.1-D71Y containing channels.
One possible mechanism to account for the observed decrease
in K+ currents when the Kir2.1-D71Y mutant subunit is coexpressed with the wild-type subunit (Fig. 2) is that there is
reduced membrane trafficking of wild-type:mutant Kir2.1 multimers compared with wild-type Kir2.1 homomeric channels.10
To examine the membrane trafficking of Kir2.1-containing
channels directly, tagged subunits were constructed as described
in Methods. Briefly, an in-frame C-terminal YFP tag was added
to the Kir2.1-D71Y subunit and an in-frame C-terminal myc tag
was added to the wild-type Kir2.1 subunit; both constructs were
expressed in HEK-293 cells. Similar to the untagged wild-type
Kir2.1 subunits, expression of Kir2.1-myc subunits resulted in
robust inwardly rectifying currents (Fig. 5A) whereas expression
of tagged Kir2.1-D71Y-YFP failed to result in any measureable
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currents (Fig. 5C). Co-expression of Kir2.1-myc subunits with
untagged Kir2.1-D71Y subunits resulted in a suppression of the
current as was seen with untagged subunits (Fig. 5B). The mean
± SEM peak current density at -120 mV was -598.2 ± 111.7 pA/
pF (n = 11) in cells expressing Kir2.1-myc and -239.6 ± 45.5 pA/
pF in cells co-expressing Kir2.1-myc and Kir2.1-D71Y (p = 0.02).
Staining of cells expressing the wild-type Kir2.1-myc subunit
revealed anti-myc staining at the cell surface (Fig. 5D). In addition, the anti-myc staining was also present in cells co-expressing
wild-type Kir2.1-myc and Kir2.1-D71Y (Fig. 5E), demonstrating
that membrane localization of wild-type Kir2.1 subunits persists
despite the marked reduction of currents in cells co-expressing
the dominant negative Kir2.1-D71Y subunit. Interestingly, in
cells expressing YFP-tagged Kir2.1-D71Y subunit, YFP fluorescence was evident at the cell surface despite the lack of detectable
currents (Fig. 5F). These results clearly suggest that the decrease
in Kir2.1-mediated currents does not result from mislocalization
of the Kir (wild-type or D71Y mutant) subunits.
Suppression of native IK1 in mouse neonatal cardiomyocytes.
Ion channel function reflects the interactions of multiple poreforming and accessory subunits as well as signaling cascades,
many of which remain incompletely characterized.13 However,
these modulatory components are often lacking in non-excitable
heterologous cell systems such as HEK-293 cells. To explore the
physiological relevance of our observations in HEK-293 cells, we
utilized mouse neonatal cardiomyocytes that express a native IK1
composed of Kir2.1 and Kir2.2.4 Transfection of isolated neonatal
cardiomyocytes with td-tomato and the human KCNJ2-G211T
cDNA construct resulted in a marked decrease in IK1 density
compared to cells transfected with td-tomato alone (Fig. 6). The
mean ± SEM peak inward current density at -120 mV was -3.3
± 0.5 pA/pF (n = 15) in cells expressing Kir2.1-D71Y compared
to -8.7 ± 3.3 pA/pF (n = 23) in cells expressing td-tomato alone
(p < 0.0001). The Kir2.1-D71Y mutation, therefore, functions
as a dominant negative mutation in an intact cellular context.
Interestingly, despite the decrease in IK1, the resting membrane
potential remained unchanged (-41 ± 2 mV in cells expressing
Kir2.1-D71Y compared to -43 ± 2 mV in cells expressing tdtomato, p = NS).
Simulations predict the effects of IK1 reduction in human
ventricular myocytes. To determine the functional consequences
of IK1 reduction in human cardiac myocytes, we utilized a recently
published model which accurately reproduces the normal repertoire of ionic currents and behavior of the human ventricular
myocyte.14 As discussed above, the residual current in the presence of Kir2.1-D71Y exhibits normal kinetic features; therefore,
IK1 kinetics in the model were not changed and the peak current
amplitude was scaled to reproduce the effects of the Kir2.1 mutations. Reduction of IK1 amplitude resulted in action potential
prolongation; notably, this prolongation was confined to the terminal portion of the action potential (Fig. 7A and Table 1). For
example, 50% reduction of IK1 resulted in no significant changes
in APD30 or APD50 whereas APD90 was prolonged by 5% and
APD99 by 13% (Table 1). In addition, no change in resting
membrane potential or action potential amplitude occurred with
reduction of IK1 amplitude (Table 1).

Figure 4. Wild-type and D71Y Kir2.1 subunits co-assemble in a complex
requiring at least 2 mutant subunits to reduce wild-type channel
function. Theoretical curves (solid symbols) were constructed predicting
the current resulting from a given percentage of wild-type subunits
under the assumption that 1, 2, 3 or 4 D71Y subunits are required to
reduce channel function. Recorded currents, resulting from varying the
percentage of wild-type subunits (50% WT, n = 11; 60% WT, n = 7; 70%
WT, n = 7; 80% WT, n = 9; WT, n = 8), are superimposed in open circles. All
data are means ± SEM. (See text and methods for further details).
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One possibility is that changes in IK1 might affect the action
potential threshold and thus contribute to the increase in ventricular ectopy, which occurs in Andersen-Tawil patients. Figure 7B
shows the amplitude-duration curve for stimuli which result in
triggered action potentials; only a trivial reduction in rheobase
(39 vs. 40 pA/pF) resulted from a 90% decrease in IK1 amplitude.
However, subthreshold stimulations resulted in a significantly
longer depolarization before the membrane voltage returned to
the resting level when IK1 levels were reduced. Figure 7C shows
illustrative examples in which a 90% reduction in IK1 results in
prolonged depolarizations in response to subthreshold stimuli.
Similar changes of a smaller magnitude were observed after a
50% reduction in IK1 amplitude (data not shown). In the context
of an intact heart, these depolarizations could increase the likelihood that a simultaneous, sub-threshold second stimulus would
generate an action potential and thus offer an explanation of the
prevalence of ectopic beats observed in patients with AndersenTawil syndrome.
Discussion

With the proliferation of disease associated mutations, it is
becoming increasingly important to determine whether an identified genetic variant is pathologic or represents background
genetic noise.15 The results reported here support the conclusion that the novel KCNJ2-G211T genetic variant identified
in a patient with Andersen-Tawil syndrome is a loss of function mutation responsible for the patient’s disease. Experiments
conducted in heterologous cells revealed that the Kir2.1-D71Y
mutant subunit co-assembles with wild-type Kir2.1 subunits
and suppresses currents without detectable effects on membrane
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Figure 5. Both mutant and wild-type Kir2.1 subunits localize to the cell surface in HEK-293 cells. Representative whole cell currents recorded from
HEK-293 cells expressing td-tomato with Kir2.1-myc (A), Kir2.1-myc + Kir2.1-D71Y (B) or Kir2.1-D71Y-YFP (C) in response to voltage steps from -120 mV to
-10 mV (10 mV increments) from a holding potential of -70 mV were normalized to cell capacitance and plotted; the dotted line indicates 0 pA/pF. (D) In
cells expressing wild-type Kir2.1-myc alone, anti-myc staining is evident at the cell surface. (E) Anti-myc staining is also evident at the cell surface when
wild-type Kir2.1-myc was co-expressed with the mutant Kir2.1-D71Y. (F) When expressed alone, the mutant Kir2.1-D71Y-YFP subunit is also evident
at the cell surface. For all parts, the (wild-type or mutant) Kir2.1 subunit staining contrasts with the cytoplasmic td-tomato fluorescence. Scale bar
= 60 μm.

Figure 6. Native IK1 in neonatal mouse ventricular myocytes is suppressed by
expression of Kir2.1-D71Y. (A and B) Representative Kir currents recorded from mouse
neonatal myocytes transfected with td-tomato alone (A) and in the presence of human
Kir2.1-D71Y (B) in response to voltage steps from -120 mV to -40 mV in 10 mV increments
from a holding potential of -70 mV and normalized to cell capacitance. (C) Mean ± SEM
peak native IK1 density measured at -120 mV in cells transfected with td-tomato alone
(solid bar) and in the presence of human Kir2.1-D71Y (open bar).

www.landesbioscience.com
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trafficking of channel subunits or current k inetics.
Additional experiments demonstrated that the
human Kir2.1-D71Y subunit suppresses native IK1
in mouse n
 eonatal cardiomyocytes, providing further support that this mutation results in IK1 channel dysfunction in vivo. Simulations predict that
in the context of the human ventricular myocyte,
this mutation will result in action potential prolongation and no change in the resting membrane
potential but a decreased stability of the membrane voltage resulting in prolonged sub-threshold
depolarizations.
Physiological roles of Kir2.1. There is general
consensus that Kir2.1 plays important roles in
regulating the electrical excitability of both cardiac
and skeletal muscle, although several previous studies have provided conflicting results regarding the
role of Kir2.1 mediated currents in the generation
of cardiomyocyte resting membrane potentials.4,16
The results of the experiments completed here, however, demonstrated that neither the co-expression
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Figure 7. Human ventricular myocyte simulations. (A) The simulated steady-state action potential in wild-type cells (heavy line) is shown with a family
of superimposed action potentials (light lines) predicted to result from progressive decreases in IK1 amplitude in 10% increments. (B) Amplitudeduration relationship for triggered action potentials is shown for wild-type (solid symbols and line) and cells with a 90% decrease in IK1 amplitude
(open symbols and dotted line). (C) Membrane potential response to stimuli of varying amplitude (as indicated in each part) in both wild-type cells
(solid line) and cells with 90% reduction in IK1 (dotted line) demonstrating both a small change in action potential threshold and prolonged membrane
depolarization in response to sub-threshold stimuli as a result of IK1 reduction.

of wild-type and mutant Kir2.1 subunits in HEK-293 cells nor
the expression of the mutant Kir2.1-D71Y in mouse neonatal
cardiomyocytes resulted in a significant change in resting membrane potential despite suppressing Kir2.1 mediated currents. In
conjunction with modeling data failing to predict a change in
human cardiomyocyte resting membrane potential, these results
suggest that the KCNJ2-G211T mutation likely does not exert its
pathologic effects via a change in resting membrane potential.
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Despite the lack of effect on resting membrane potential, IK1
could play a role in membrane stability and excitability. Due to
the fact that cellular excitability depends on the aggregate effects
of an array of species-specific ion channels, an in silico model of
the human ventricular myocyte was used to explore the role of
IK1 in membrane stability. Interestingly, simulation results indicated that IK1 plays an important role in the rate at which the
membrane returns to the resting potential after a perturbation.
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Table 1. Simulated action potential parameters resulting from IK1
reduction in a human ventricular myocyte model
Wild-type

50% IK1
reduction

90% IK1
reduction

Resting Vm (mV)

-88

-88

-89

Action potential amplitude
(mV)

128

128

130

APD30 (ms)

165

164

164

APD50 (ms)

207

206

207

APD90 (ms)

266

278

304

APD99 (ms)

286

322

552

No significant change occurred in resting membrant potential (Vm), action
potential amplitude, or action potential duration measured at 30% or
50% repolarization (APD30 and APD50) whereas action potential d
 uration
at 90% and 99% repolarization (APD90 and APD99) was p
 rolonged.

Sub-threshold stimuli resulted in a prolonged depolarization in
the setting of IK1 reduction. This finding suggests a novel mechanism by which IK1 reduction contributes to arrhythmias, i.e., by
generating sub-threshold depolarizations that could summate to
result in ectopic activation.
Inwardly rectifying K+ currents have also been suggested to
play an important role in the repolarization phase of the action
potential and in the stability of ventricular arrhythmias.3 Previous
studies using either knock-out or dominant-negative strategies
in mice and guinea pig have demonstrated action potential prolongation.4,16,17 In this study, the human cardiac myocyte model
predicted action potential prolongation confined to the terminal
portion of the action potential. This finding is consistent with
published results on guinea pig cardiomyocytes but contrasts
with studies of mouse cardiomyocytes which exhibited action
potential prolongation at both APD50 and APD90.4,17 These
observations emphasize the potentially species-specific nature of
electrophysiological perturbations reflecting differences in ion
channel expression and function.
Kir2.1, as well as many related Kir family members, is expressed
in a wide variety of tissues, a fact that is consistent with the clinical observations that patients harboring mutations in KCNJ2
exhibit a complex phenotype affecting multiple tissues.2 The
patient carrying this KCNJ-G211T2 mutation suffered periodic
paralysis, cardiac ectopy and skeletal abnormalities consistent
with a role for Kir2.1 channels in the function of skeletal muscle,
cardiac m
 yocytes and bone development. It has been shown that
inward rectifying currents are present in osteoclasts where they
are believed to offset the hyperpolarization induced by proton
export.2 In addition to its role in electrical excitability, Kir2.1
expression in skeletal muscle is involved in myotube fusion.2
Kir2.1 structure and function. Andersen-Tawil syndrome
associated mutations have been reported throughout the sequence
of KCNJ2, including the transmembrane helices, the ion selectivity filter, the slide-helix and the N- and C-termini.18 Most of the
identified Andersen-Tawil syndrome associated mutations result
in dominant-negative suppression of wild-type Kir2.1-mediated
currents through multiple mechanisms. Previous KCNJ2 mutations located in the PIP2 binding domain have been shown to

alter PIP2 affinity,19 a mutation in the slide helix has been shown
to alter both magnesium and PIP2 sensitivity,20 and mutations
in multiple regions have been associated with altered membrane
localization.10,21 Interestingly, additional mutations located in
the slide helix region have been shown to function as dominant
negative loss of function mutations without affecting membrane
localization or PIP2 binding affinity.9 Similar to several previously
reported mutations,9 the D71Y mutation reported here is located
in the slide helix region of the Kir2.1 (Fig. 1B) and does not
affect membrane localization. In addition, we report here that
the presence of D71Y mutation has no effect on current kinetics,
indicating that either this region does not directly participate in
channel gating or that this mutation renders the channel entirely
non-functional, thus leaving a (normal) residual current composed of solely wild-type subunits.
Methods
cDNA constructs. A cDNA encoding human KCNJ2 was
obtained from Open Biosystems and a PCR product containing the open reading frame with added EcoR1 and Xho1 sites
was subcloned into the mammalian expression vector pCMV
Script (Clontech). PCR site-directed mutagenesis was carried
out using the QuickChange XL kit (Stratagene); the mutated
gene was subcloned into pCMV Script and the final construct
was sequenced to verify the mutation and to exclude PCR errors.
In addition, the KCNJ2 cDNA was subcloned into pCMV
c-myc (Clontech) and the KCNJ2-G211T cDNA was subcloned
into pEYFP-N1 (Clontech) to generate myc- and YFP-tagged
subunits, respectively.
Cell culture and transfections. Human embryonic kidney-293
(HEK-293) cells were maintained in Dulbecco’s Modified Eagle
Medium (DMEM-Gibco, Invitrogen, 11965) supplemented with
5% fetal bovine serum (Atlas Biological, FP-0500-A), 5% horse
serum (Gibco, Invitrogen, 26050), and penicillin/streptomycin
(Gibco, Invitrogen, 15140) in a 37°C 95% air/5% CO2 incubator. Mouse neonatal cardiomyocytes were isolated from post-natal
day 1–3 pups anesthetized with isoflurane and euthanized by
decapitation. After removing the hearts, ventricles were dissected
and minced in Hanks Balanced Salt Solution (HBSS), containing in mM: 127 NaCl (Sigma, S5886), 5.4 KCl (Sigma, P9541),
4.2 NaHCO3 (Sigma, S5761), 0.4 Na 2HPO4 (Sigma, S5011),
0.44 KH2PO4 (Sigma, P5655), 5.5 glucose (Sigma, G6152), and
penicillin/streptomycin. The ventricular pieces were incubated
overnight in HBSS containing 0.1% trypsin (T8003, Sigma) followed by a 30 min incubation at 37°C. The tissue was triturated,
centrifuged at 300x g, and resuspended in DMEM supplemented
with 20% fetal calf serum and penicillin/streptomycin. Cells
were plated on tissue culture plates for 1 h at 37°C to allow adhesion of fibroblasts. Cells in suspension were then plated on collagen (type 1, Sigma, C9791)-coated coverslips at low density and
transfected after 24 h incubation at 37°C.
Transient transfections were carried out using Lipofectamine
2000 (Invitrogen) as previously described in reference 22. All
transfections were performed with 1 μg of wild-type vector,
variable amounts of mutant vectors, and variable amounts of
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empty vector to result in a total of 2 μg of DNA in all transfections. Additionally, 0.25 μg of pCMV-td-tomato plasmid was
added to all transfections to allow identification of transfected
cells.
Whole-cell recordings. Twenty-four to 36 h (for HEK293 cells) or 24–48 h (for neonatal myocytes) after transfection, whole-cell K+ currents were recorded at room temperature
(20–23°C) using previously described solutions and protocols.22,23 Recording pipettes fashioned from borosilicate glass
(WPI, TW150F-4) had resistances of 2–3 MΩ when filled with
recording solution. Experiments were controlled by and data
were collected using an Axopatch 1D, digitized with a Digidata
1322A and stored on a Gateway PC running Clampex 9.2
(all Molecular Devices).
Data analysis. Data were analyzed using ClampFit
(Molecular Devices), Excel (Microsoft) and Prism (GraphPad).
Only cells with a membrane resistance >300 MΩ and an access
resistance <15 MΩ were analyzed. Membrane capacitance
and input resistance were measured by analyzing the decay
phases of the capacitive current elicited by a 20 ms voltage step
(±10 mV) from a holding potential of -40 mV, as described previously in reference 23. Peak Kir currents were measured by averaging the current during 10 ms at the maximal current evoked
at each test potential. Steady state Kir currents were measured
340 ms after the onset of the voltage steps. Instantaneous Kir
currents were measured at the end of the initial capacitive transient. The time course of current activation was determined by
fitting the current trace from the end of the capacitive transients to the peak current with a mono-exponential function.
All data were tested for normalcy and subsequently analyzed
with a one- or two-way ANOVA, Kruskal-Wallis, unpaired
t-test or Mann-Whitney U test as appropriate. All results are
reported as means ± SEM.
Immunohistochemistry. Thirty-six hours after transfections,
HEK-293 cells were washed in phosphate buffered saline (PBS)
and fixed with 4% paraformaldehyde for 20 min. Cells were
incubated for 1 h in blocking buffer (PBS with 5% goat serum
and 0.2% Triton X-100) followed by incubations with primary
and secondary antibodies [1:1,000 mouse anti-myc monoclonal
antibody (Millipore), 1:1,000 Alexa 488 goat anti-mouse antibody (Invitrogen)] in blocking buffer for 1–2 h each at room
temperature. After washing in PBS, coverslips were mounted
in ProLong Gold antifade solution (Invitrogen). Cells were
imaged on a Nikon Eclipse inverted microscope equipped with
a CoolSNAP CCD (Photometrics); images were acquired using
Volocity 4 (Improvision, PerkinElmer) software.
Calculation of channel stochiometry. The number of mutant
subunits required to reduce channel function was estimated
using previously described methods in reference 24. Briefly, the
distribution of possible combinations of four subunits, each of
which can be either wild-type or mutant, follows a binomial
distribution. The probability of a channel containing 1, 2, 3 or

4 mutant subunits can be calculated from the probability mass
function

where Pk = probability that a channel contains k mutant subunits,
n = total number of subunits, k = number of mutant subunits and
p = probability of incorporation of a mutant subunit (assumed
to be equal to the proportion of transfected mutant cDNA).
Assuming that the decrease in current is proportional to the percentage of dysfunctional channels, this allows the generation of
a family of theoretical curves predicting the decrease in current
based on the hypotheses that one, two, three or four mutant subunits are required to reduce channel function. The current resulting from different ratios of wild-type and mutant subunits is then
recorded and the data fit to the best theoretical curve.
Simulations. Simulations were carried out using a model of
human endocardial ventricular myocytes using the published
O’Hara-Rudy dynamic model14 with the addition of a scaling
factor to reduce IK1 amplitude. All simulations were carried out
for 1,000 beats to ensure steady state conditions. Amplitudeduration curves were constructed by determining the minimal
stimulus amplitude required to trigger an action potential for
each stimulus duration; the resulting curve was fitted with a single exponential function, using Prism to determine the rheobase.
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Conclusion

In summary, the experiments presented here demonstrate that
a novel G211T mutation in KCNJ2 identified in a patient with
all of the cardinal features of Andersen-Tawil syndrome results
in the production of mutant Kir2.1-D71Y protein that functions
as a dominant negative to suppress endogenous IK1. The mutant
subunit reduces wild-type Kir2.1 currents in both HEK-293 cells
and neonatal mouse cardiomyocytes, without measureable effects
on membrane localization, current kinetics or resting membrane
potentials. Simulations predict that these effects would lead to
a prolongation of the human cardiomyocyte action potential
and to destabilization of the resting membrane potential. These
observations are interpreted as suggesting that this mutation is
responsible for the patient’s clinical syndrome.
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